Intended for healthcare professionals


Covid-19: The inside story of the RECOVERY trial

BMJ 2020; 370 doi: (Published 10 July 2020) Cite this as: BMJ 2020;370:m2800

This feature article (BMJ 2020;370:m2670, doi:10.1136/bmj.m2670) stated in Box 4 that The BMJ understood Mene Pangalos, executive vice president of biopharmaceuticals R&D at AstraZeneca, to be a member of the ACCORD therapeutics taskforce. AstraZeneca has responded to say that this is not the case, and we have removed the sentence.

View Abstract